September 2025

Filter:

The impact of tokenism and potential exploitation of minorities on community engagement: Models for sustainable and genuine co-design

This article examines how tokenism in health research and care undermines trust and outcomes, highlighting global examples of genuine, community-led collaboration that show the impact of ethical, co-designed, and culturally sensitive approaches to improving healthcare equity.

23 October 2025 | By Ishani Sharma

Pharmacologist in Phrame - Dr Mark Soave

Dr Mark Soave shares his journey from academic research to industry, reflecting on how a curiosity for drug development and molecular pharmacology led him to OMass Therapeutics. In this interview, he discusses the value of mentorship, the importance of animal models in pharmacology, and the lessons he's learned along the way, both in the lab and beyond.

Read the full

10 October 2025 | By Dr Mark Soave

The wacky world of working with worms!

It has become a recurring joke amongst regular attendees at Society meetings that whenever I show up, you are going to hear about something to do with worms…

11 August 2025 | By Dr. Aidan Seeley

The future of antibiotics: how frog-derived peptides could combat drug-resistant bacteria

Antibiotic resistance is one of the greatest threats to modern medicine. Once-powerful drugs are losing their effectiveness, leaving doctors with limited options against deadly bacterial infections. But what if the key to the next generation of antibiotics comes not from a laboratory, but from nature itself?

11 August 2025 | By Yasmin Dickinson

"No more lab animals?” - FDA to phase out animal testing requirement

For decades, animal models have played a crucial role in biomedical research and drug development. From understanding disease mechanisms to evaluating drug safety, studies involving animal work have helped to lay the groundwork for many of the medical advances we benefit from today. However, as scientific innovation continues to evolve, so does our ability to explore safer, more precise, and humane alternatives.

11 August 2025 | By Yasmin Dickinson

Reflections from three years supporting BPS Content

Managing Editor Chloe Gynne signs off from her post with a reflection on her highlights of working with the BPS Content Board.

19 June 2025 | By Chloe Gynne

Pharmacologist in Phrame: Professor Catriona Waitt

Catriona Waitt is a Professor of Clinical Pharmacology and Global Health at the University of Liverpool, and working at the Makerere University, Kampala, Uganda. Here, she discusses her research interests, how she has developed her career, and her advice for others.

17 June 2025 | By Aisah Aubdool, Catriona Waitt

Animal testing and the 3Rs: Replacement

Hannah Roughley continues her series on animal research with an exploration of replacement as one of the 3Rs. Co-authored with Dr Shoebul Haque, this article examines recent advancements which have made replacement increasingly possible.

16 May 2025 | By Hannah Roughley, Shoebul Haque

Announcing the winner of the 2025 Pharmacomedy competition

We are pleased to share the results of the first Pharmacomedy competition, which ran from December 2024-January 2025.

09 May 2025 | By Alistair Corbett, Graeme Henderson

The power of team science in drug discovery: A perspective on doctoral training for the next generation of pharmaceutical scientists

The Drug Discovery and Team Science Doctoral Training Programme (DTP) at the University of Nottingham explore how team science enhances the effectiveness of drug discovery (in this case, for pain and addiction studies), and transforms doctoral training through robust financial support and training, fostering diversity, and preparing researchers for collaborative careers.

29 April 2025 | By George J Farmer, Megan Greener, Charles Besidonne and Lauren Brown

World’s Most Expensive Drug: Zolgensma

In the fight against spinal muscular atrophy (SMA), few treatments have reshaped the landscape like Zolgensma (onasemnogene abeparvovec). Priced at a staggering $2.1 million per patient for a one-time dose, it was the world’s most expensive drug at the time of its FDA approval in 2019. Although its innovative mechanism of action offers hope for those diagnosed with SMA, its price tag raises a critical question: how can one justify the cost?

24 April 2025 | By Bartosz Pajak

Meet the Lab: MILK and At the EQUATOR Team

Running a clinical research team is a complex progress, but seeing the team come to life must be an amazing experience. In this edition of Meet The Lab, PM Editor-in-Chief Aisah Aubdool spoke to Professor Catriona Waitt and her team to learn about her research group at the University of Liverpool and Infectious Diseases Institute, Makerere University, Uganda.

26 March 2025 | By Aisah Aubdool, Catriona Waitt

Reflections of an ancient pharmacologist

Emeritus Professor Jim Parratt has been a pharmacologist since the 1950s, and his first BPS meeting was in 1956. Here, he tells us about a remarkable life devoted to pharmacology.

20 January 2025 | By Emeritus Professor Jim Parratt

Open now: BPS PharmaComedy Competition

Make us laugh by sharing your best original jokes, memes and videos to be in with a chance to win a £100 cash prize! Make sure you enter before 26 January 2025 - the punnier, the better.

06 December 2024 | By Graeme Henderson & Alistair Corbett

Animal testing and the 3Rs: An introduction

Hannah Roughley begins her new series on animal research with an explanation of the 3Rs, one of the key pillars of this important part of drug research and development. This series will explore the 3Rs in further detail and explore the ethical implications and considerations of animal research.

06 November 2024 | By Hannah Roughley

Load More Posts